Estradiol with norethisterone - Menopausal disorders
You are here : Home > Formulary Search > Estradiol with norethisterone - Menopausal disorders
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Status 1
Green (see narrative)
Formulations :
- Patches
Formulary Status :
Associated Icons :
Restrictions / Comments :
Important
Evorel Sequi patches 2nd-line. Preferred option in women with risk factors for VTE or migraine.
Status 2
Green (see narrative)
Formulations :
- Tablets
Formulary Status :
Associated Icons :
Restrictions / Comments :
Important
Elleste Duet tablets 2nd line. For women requiring sequential combined therapy but with poor cycle control on Femoston (1st-line).
Status 3
Green (see narrative)
Formulations :
- Tablets
Formulary Status :
Associated Icons :
Restrictions / Comments :
Important
Novofem tablets - Only use if there are product shortages with Elleste Duet
Status 4
Green (see narrative)
Formulations :
- Tablets
Formulary Status :
Associated Icons :
Restrictions / Comments :
Important
Elleste Duet Conti - 2nd line for women requiring continuous combined therapy but with poor cycle control on Femoston Conti (1st-line).
Status 5
Green (see narrative)
Formulations :
- Patches
Formulary Status :
Associated Icons :
Restrictions / Comments :
Important
Evorel Conti patches - preferred in women with risk factors for VTE or migraine. Otherwise use a 1st-line oral option.
Status 6
Green (see narrative)
Formulations :
- Tablets
Formulary Status :
Associated Icons :
Restrictions / Comments :
Important
Kliofem tablets - 2nd line in women requiring continuous combined therapy but with poor cycle control on Femoston Conti (1st-line)
Status 7
Green (see narrative)
Formulations :
- Tablets
Formulary Status :
Associated Icons :
Restrictions / Comments :
Important
Kliovance tablets - 2nd line in women requiring continuous combined therapy but with poor cycle control on Femoston Conti (1st-line)
Status 8
Non Formulary
Formulations :
- Tablets
Formulary Status :
Associated Icons :
Restrictions / Comments :
Important
Trisequens tablets - consider changing to newer, 1st or 2nd line options.
Documentation
PAD Profile
ChemicalSubstance :
Estradiol with norethisterone
Indication :
Menopausal disorders
Group Name :
Keywords :
hormone replacement therapy, HRT, menopause, sequential combined therapy, continuous combined therapy, menopausal symptoms
Brand Names Include :
Evorel Sequi, Elleste Duet, Novofem, Trisequens, Elleste Duet Conti, Evorel Conti, Kliofem, Kliovance
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1
Traffic Light Entries :
8
Other Indications
Below are listed other indications that Estradiol with norethisterone is used to treat.
- No records returned.
Other Drugs
Below are listed other drugs that are used to treat Menopausal disorders.
- Clonidine hydrochloride
- Conjugated oestrogens
- Conjugated oestrogens with medroxyprogesterone
- Drospirenone
- Estradiol
- Estradiol with dydrogesterone
- Estradiol with levonorgestrel
- Estradiol with medroxyprogesterone
- Estradiol with progesterone
- Ethinylestradiol
- Gabapentin
- Levonorgestrel
- Medroxyprogesterone acetate
- Paroxetine
- Pregabalin
- Progesterone
- St Johns Wort
- Tibolone
- Venlafaxine
Committee Recommendations (1)
The Surrey Heartlands APC has agreed a traffic light status and place in therapy for the treatments of menopausal disorders in line with the CKS recommenations: